Alzheimer's breakthrough: Genetic link to gut disorders confirmed

by Edith Cowan UniversityClusters of significantly enriched biological pathways for AD and GERD.aKEGG: Kyoto Encyclopedia of Genes and Genomes pathways:intestinal immune network

Updated on: February 19,2024

Alzheimer's breakthrough: Genetic link to gut disorders confirmed

by Edith Cowan UniversityClusters of significantly enriched biological pathways for AD and GERD.aKEGG: Kyoto Encyclopedia of Genes and Genomes pathways:intestinal immune network

Updated on:February 19,2024

Upadacitinib superior to placebo in moderate-to-severe Crohn disease

by Elana GotkineFor patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the&

Updated on: February 19,2024

Upadacitinib superior to placebo in moderate-to-severe Crohn disease

by Elana GotkineFor patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the&

Updated on:February 19,2024

ChatGPT does not pass American College of Gastroenterology tests

by Elana GotkineThe natural language processing model Chat Generative Pretrained Transformer (ChatGPT) does not pass the American College of Gastroenterology (ACG) Self-Assessment Tests, according to

Updated on: February 19,2024

ChatGPT does not pass American College of Gastroenterology tests

by Elana GotkineThe natural language processing model Chat Generative Pretrained Transformer (ChatGPT) does not pass the American College of Gastroenterology (ACG) Self-Assessment Tests, according to

Updated on:February 19,2024

FDA approves first pill to treat moderate-to-severe Crohn's disease

by Cara MurezPatients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).Rinvoq is meant to treat adults

Updated on: February 19,2024

FDA approves first pill to treat moderate-to-severe Crohn's disease

by Cara MurezPatients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).Rinvoq is meant to treat adults

Updated on:February 19,2024

ACG issues guideline for management of upper GI bleeding

(HealthDay)—In an American College of Gastroenterology clinical guideline, published in the May issue of theAmerican Journal of Gastroenterology, recommendations are presented for the mana

Updated on: February 19,2024

ACG issues guideline for management of upper GI bleeding

(HealthDay)—In an American College of Gastroenterology clinical guideline, published in the May issue of theAmerican Journal of Gastroenterology, recommendations are presented for the mana

Updated on:February 19,2024

Endoscopy within six hours does not lower mortality in GI bleed

(HealthDay)—Endoscopy within six hours versus six to 24 hours after consultation is not associated with lower 30-day mortality in patients with acute upper gastrointestinal bleeding who are at high ri

Updated on: February 19,2024

Endoscopy within six hours does not lower mortality in GI bleed

(HealthDay)—Endoscopy within six hours versus six to 24 hours after consultation is not associated with lower 30-day mortality in patients with acute upper gastrointestinal bleeding who are at high ri

Updated on:February 19,2024

Opioids frequently prescribed to patients with cirrhosis

by Elana Gotkine HealthDay ReporterOpioids are frequently prescribed to patients with cirrhosis, often without a pain diagnosis, according to a research letter published online Dec. 8 inClinical

Updated on: February 19,2024

Opioids frequently prescribed to patients with cirrhosis

by Elana Gotkine HealthDay ReporterOpioids are frequently prescribed to patients with cirrhosis, often without a pain diagnosis, according to a research letter published online Dec. 8 inClinical

Updated on:February 19,2024

Risk for adverse events not increased after COVID-19 vaccine in IBD

(HealthDay)—Individuals with inflammatory bowel disease (IBD) do not have an increased risk for adverse events (AEs) after the mRNA COVID-19 vaccination, according to a study published online May 25 i

Updated on: February 19,2024

Risk for adverse events not increased after COVID-19 vaccine in IBD

(HealthDay)—Individuals with inflammatory bowel disease (IBD) do not have an increased risk for adverse events (AEs) after the mRNA COVID-19 vaccination, according to a study published online May 25 i

Updated on:February 19,2024

Bloodstream infections in preemies may originate from their gut microbiomes

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainDangerous bacterial bloodstream infections in preemies may originate from the infants' gut microbiomes, according

Updated on: February 19,2024

Bloodstream infections in preemies may originate from their gut microbiomes

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainDangerous bacterial bloodstream infections in preemies may originate from the infants' gut microbiomes, according

Updated on:February 19,2024

Response to COVID-19 vaccine positive in patients with IBD

(HealthDay)—Inflammatory bowel disease (IBD) patients taking biologics achieved a positive antibody response to both the Moderna and Pfizer COVID-19 vaccines, according to research published online Ap

Updated on: February 19,2024

Response to COVID-19 vaccine positive in patients with IBD

(HealthDay)—Inflammatory bowel disease (IBD) patients taking biologics achieved a positive antibody response to both the Moderna and Pfizer COVID-19 vaccines, according to research published online Ap

Updated on:February 19,2024

MRI index can predict postop recurrence in Crohn disease

A magnetic resonance imaging (MRI) index has been developed and validated for predicting postoperative recurrence (POR) in Crohn disease (CD), according to a study published in the May issue ofC

Updated on: February 19,2024

MRI index can predict postop recurrence in Crohn disease

A magnetic resonance imaging (MRI) index has been developed and validated for predicting postoperative recurrence (POR) in Crohn disease (CD), according to a study published in the May issue ofC

Updated on:February 19,2024

Ozanimod beats placebo for ulcerative colitis

(HealthDay)—For patients with moderately to severely active ulcerative colitis, ozanimod is more effective than placebo as induction and maintenance therapy, according to a study published in the Sept

Updated on: February 19,2024

Ozanimod beats placebo for ulcerative colitis

(HealthDay)—For patients with moderately to severely active ulcerative colitis, ozanimod is more effective than placebo as induction and maintenance therapy, according to a study published in the Sept

Updated on:February 19,2024